Ralf Regenthal

3.2k citations

77 papers · 2.3k indexed · h-index 25

Impact in

Cognitive Neuroscience top 2%
- Functional Brain Connectivity Studies
- Neural and Behavioral Psychology Studies
- Neural dynamics and brain function
Psychiatry and Mental health top 2%
- Attention Deficit Hyperactivity Disorder

Papers in ⓘ

Cognitive Neuroscience 23
- Neural and Behavioral Psychology Studies 15
- Functional Brain Connectivity Studies 14
- Neural dynamics and brain function 7
Cellular and Molecular Neuroscience 19
- Neuroscience and Neuropharmacology Research 10
- Neurotransmitter Receptor Influence on Behavior 7

Co-authors: Trevor W. Robbins (19 shared papers)Rainer Preiß (9 shared papers)Barbara J. Sahakian (13 shared papers)James B. Rowe (12 shared papers)Peter Bublak (2 shared papers)Roger A. Barker (9 shared papers)Ute Krügel (10 shared papers)Timothy Rittman (6 shared papers)
Journals: Brain (6 papers)Psychopharmacology (6 papers)Biological Psychiatry (4 papers)Human & Experimental Toxicology (3 papers)Human Brain Mapping (2 papers)
Partner nations: Germany United Kingdom Czechia

In The Last Decade

Ralf Regenthal

76 papers receiving 2.2k citations

Peers

Countries citing papers authored by Ralf Regenthal

Since Specialization

Citations

This map shows the geographic impact of Ralf Regenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Regenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Regenthal more than expected).

Fields of papers citing papers by Ralf Regenthal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Regenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Regenthal. The network helps show where Ralf Regenthal may publish in the future.

Co-authors

The 25 scholars most cited alongside Ralf Regenthal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ralf Regenthal Line = papers co-authored together Ralf Regenthal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Drug Levels: Therapeutic and Toxic Serum/Plasma Concentrations of Common Drugs Journal of Clinical Monitoring and Computing ·Ralf Regenthal, Mario Krueger, Claus Koeppel, Rainer Preiß	1999	244
2	Atomoxetine Modulates Right Inferior Frontal Activation During Inhibitory Control: A Pharmacological Functional Magnetic Resonance Imaging Study Biological Psychiatry ·Samuel R. Chamberlain, Adam Hampshire, Ulrich Müller, Katya Rubia, Natalia del Campo, Kevin J. Craig, Ralf Regenthal, John Suckling, Jonathan P. Roiser, Jon E. Grant, Edward T. Bullmore, Trevor W. Robbins, Barbara J. Sahakian	2008	232
3	Effects of modafinil on working memory processes in humans Psychopharmacology ·Ulrich M�ller, Nikolai Steffenhagen, Ralf Regenthal, Peter Bublak	2004	129
4	Targeting impulsivity in Parkinson’s disease using atomoxetine Brain ·Angie A. Kehagia, Charlotte R. Housden, Ralf Regenthal, Roger A. Barker, Ulrich Müller, James B. Rowe, Barbara J. Sahakian, Trevor W. Robbins	2014	112
5	Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study Psychopharmacology ·Kathrin Finke, Chris Dodds, Peter Bublak, Ralf Regenthal, Frank Baumann, Tom Manly, Ulrich Müller	2010	103
6	Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease Brain ·Zheng Ye, Ellemarije Altena, Cristina Nombela, Charlotte R. Housden, Helen Maxwell, Timothy Rittman, Chelan Huddleston, Charlotte L. Rae, Ralf Regenthal, Barbara J. Sahakian, Roger A. Barker, Trevor W. Robbins, James B. Rowe	2014	97
7	Improving Response Inhibition in Parkinson’s Disease with Atomoxetine Biological Psychiatry ·Zheng Ye, Ellemarije Altena, Cristina Nombela, Charlotte R. Housden, Helen Maxwell, Timothy Rittman, Chelan Huddleston, Charlotte L. Rae, Ralf Regenthal, Barbara J. Sahakian, Roger A. Barker, Trevor W. Robbins, James B. Rowe	2014	85
8	A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment Brain ·Natalia del Campo, Tim D. Fryer, Young T. Hong, Rob Smith, Laurent Brichard, Julio Acosta‐Cabronero, Samuel R. Chamberlain, Roger Tait, David Izquierdo‐Garcia, Ralf Regenthal, J. H. Dowson, John Suckling, Jean‐Claude Baron, Franklin I. Aigbirhio, Trevor W. Robbins, Barbara J. Sahakian, Ulrich Müller	2013	83
9	Atomoxetine restores the response inhibition network in Parkinson’s disease Brain ·Charlotte L. Rae, Cristina Nombela, Patricia Vázquez Rodríguez, Zheng Ye, Laura E. Hughes, P. Simon Jones, Timothy Ham, Timothy Rittman, Ian Coyle‐Gilchrist, Ralf Regenthal, Barbara J. Sahakian, Roger A. Barker, Trevor W. Robbins, James B. Rowe	2016	77
10	Serotonergic Modulation of Intrinsic Functional Connectivity Current Biology ·Alexander Schaefer, Inga Burmann, Ralf Regenthal, Katrin Arélin, Cláudia Barth, André Pampel, Arno Villringer, Daniel S. Margulies, Julia Sacher	2014	73
11	Improving response inhibition systems in frontotemporal dementia with citalopram Brain ·Laura E. Hughes, Timothy Rittman, Ralf Regenthal, Trevor W. Robbins, James B. Rowe	2015	66
12	Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans Neuropsychopharmacology ·Nikolina Skandali, James B. Rowe, Valerie Voon, Julia Deakin, Rudolf N. Cardinal, Francesca Cormack, Luca Passamonti, W Richard Bevan‐Jones, Ralf Regenthal, Samuel R. Chamberlain, Trevor W. Robbins, Barbara J. Sahakian	2018	63
13	Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease Brain ·Claire O’Callaghan, Frank H. Hezemans, Rong Ye, Catarina Rua, P Simon Jones, Alexander G. Murley, Negin Holland, Ralf Regenthal, Kamen A. Tsvetanov, Noham Wolpe, Roger A. Barker, Caroline H. Williams‐Gray, Trevor W. Robbins, Luca Passamonti, James B. Rowe	2021	59
14	Altered serotonin transporter availability in patients with multiple sclerosis European Journal of Nuclear Medicine and Molecular Imaging ·Swen Hesse, Franziska Moeller, David Petroff, Donald Lobsien, Julia Luthardt, Ralf Regenthal, Georg‐Alexander Becker, Marianne Patt, Eva Thomae, Anita Seese, Philipp Meyer, Florian Then Bergh, Osama Sabri	2014	56
15	Changes in purinergic signaling after cerebral injury – involvement of glutamatergic mechanisms? International Journal of Developmental Neuroscience ·Heike Franke, Benjamin Grummich, Wolfgang Härtig, Jens Grosche, Ralf Regenthal, Robert H. Edwards, Péter Illés, Ute Krügel	2006	56
16	The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory Psychopharmacology ·Chris Dodds, Luke Clark, Anja Dove, Ralf Regenthal, Frank Baumann, Edward T. Bullmore, Trevor W. Robbins, Ulrich Müller	2009	53
17	Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures Human Brain Mapping ·Zheng Ye, Charlotte L. Rae, Cristina Nombela, Timothy Ham, Timothy Rittman, P. Simon Jones, Patricia Vázquez Rodríguez, Ian Coyle‐Gilchrist, Ralf Regenthal, Ellemarije Altena, Charlotte R. Housden, Helen Maxwell, Barbara J. Sahakian, Roger A. Barker, Trevor W. Robbins, James B. Rowe	2016	53
18	Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity Free Radical Biology and Medicine ·Susana Garcia de Arriba, Ute Krügel, Ralf Regenthal, Z Vissiennon, Ester Verdaguer, Anne Lewerenz, Elvira García‐Jordà, Mercè Pallàs, Antoni Camins, Gerald Münch, K Nieber, Clemens Allgaier	2005	51
19	The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive–compulsive disorder The International Journal of Neuropsychopharmacology ·Swen Hesse, Katarina Stengler, Ralf Regenthal, Marianne Patt, Georg‐Alexander Becker, Annegret Franke, Heike Knüpfer, Philipp Meyer, Julia Luthardt, Ina Jahn, Donald Lobsien, Wolfgang Heinke, Peter Brust, Ulrich Hegerl, Osama Sabri	2011	45
20	Determination of nicotine and cotinine in human serum by means of LC/MS Journal of Chromatography B ·Frank Baumann, Ralf Regenthal, I.L. Burgos-Guerrero, Ulrich Hegerl, Rainer Preiß	2009	34

About Ralf Regenthal

Ralf Regenthal is a scholar working on Cognitive Neuroscience, Cellular and Molecular Neuroscience, Psychiatry and Mental health, Behavioral Neuroscience and Pharmacology, having authored 77 papers that have together received 2.3k indexed citations. Recurring topics across this work include Neural and Behavioral Psychology Studies (15 papers), Functional Brain Connectivity Studies (14 papers), Neuroscience and Neuropharmacology Research (10 papers), Neurological disorders and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers), Neurotransmitter Receptor Influence on Behavior (7 papers), Neural dynamics and brain function (7 papers) and Receptor Mechanisms and Signaling (5 papers). The work is most often cited by research in Cognitive Neuroscience (901 citations), Psychiatry and Mental health (482 citations), Biological Psychiatry (77 citations), Cellular and Molecular Neuroscience (551 citations) and Neurology (414 citations). Ralf Regenthal has collaborated with scholars based in Germany, United Kingdom and Czechia. Frequent co-authors include Trevor W. Robbins, Rainer Preiß, Barbara J. Sahakian, James B. Rowe, Peter Bublak, Roger A. Barker, Ute Krügel, Timothy Rittman, Frank Baumann and Ulrich M�ller. Their work appears in journals such as Brain, Psychopharmacology, Biological Psychiatry, Human & Experimental Toxicology and Human Brain Mapping.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact